- Home
- PROP vs KRRO Comparison
PROP vs KRRO Comparison
Compare PROP & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROP
- KRRO
- Stock Information
- Founded
- PROP 2001
- KRRO 2014
- Country
- PROP United States
- KRRO United States
- Employees
- PROP N/A
- KRRO N/A
- Industry
- PROP Investment Bankers/Brokers/Service
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- PROP Finance
- KRRO Health Care
- Exchange
- PROP Nasdaq
- KRRO Nasdaq
- Market Cap
- PROP 190.0M
- KRRO 209.6M
- IPO Year
- PROP N/A
- KRRO 2019
- Fundamental
- Price
- PROP $4.53
- KRRO $15.40
- Analyst Decision
- PROP
- KRRO Strong Buy
- Analyst Count
- PROP 0
- KRRO 7
- Target Price
- PROP N/A
- KRRO $90.67
- AVG Volume (30 Days)
- PROP 374.3K
- KRRO 103.7K
- Earning Date
- PROP 01-01-0001
- KRRO 05-07-2025
- Dividend Yield
- PROP N/A
- KRRO N/A
- EPS Growth
- PROP N/A
- KRRO N/A
- EPS
- PROP N/A
- KRRO N/A
- Revenue
- PROP $7,939,000.00
- KRRO $4,821,000.00
- Revenue This Year
- PROP $8,955.68
- KRRO N/A
- Revenue Next Year
- PROP N/A
- KRRO $55.56
- P/E Ratio
- PROP N/A
- KRRO N/A
- Revenue Growth
- PROP N/A
- KRRO N/A
- 52 Week Low
- PROP $3.35
- KRRO $11.13
- 52 Week High
- PROP $15.68
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- PROP 50.55
- KRRO 45.11
- Support Level
- PROP $4.27
- KRRO $15.85
- Resistance Level
- PROP $4.57
- KRRO $22.15
- Average True Range (ATR)
- PROP 0.31
- KRRO 2.40
- MACD
- PROP 0.16
- KRRO 0.11
- Stochastic Oscillator
- PROP 89.34
- KRRO 24.24
About PROP Prairie Operating Co.
Prairie Operating Co is a Houston-based independent energy company engaged in the development and acquisition of oil and natural gas resources in the United States. The Company's assets and operations are concentrated in the oil and liquids-rich regions of the Denver-Julesburg (DJ) Basin, with a focus on the Niobrara and Codell formations. The Company is committed to the responsible development of its oil and natural gas resources and is focused on maximizing returns through consistent growth, capital discipline, and sustainable cash flow generation.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.